I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Spoorendonk, J. A.
98
results:
Format
Online (95)
Print (3)
Mediatypes
Articles (Online) (37)
Articles (Print) (1)
Bookchapter (Print) (2)
OpenAccess-fulltext (58)
Languages
german (7)
english (62)
Sorted by: Relevance
Sorted by: Year
?
1
Clinical implications and cost-effectiveness analysis of ri..:
Spoorendonk, J. A.
;
Briere, J.-B.
;
Bowrin, K.
...
Journal of Medical Economics. 24 (2021) 1 - p. 1231-1239 , 2021
Link:
https://doi.org/10.1080/..
?
2
PCN21 Efficacy and Safety in Previously Untreated, Advanced..:
Kraan, C.W.
;
Nientker, L.
;
May, J.
...
Value in Health. 23 (2020) - p. S424 , 2020
Link:
https://doi.org/10.1016/..
?
3
PCN183 Global Incidence, Prevalence, and Survival in Relaps..:
Spoorendonk, J.
;
Feng, C.
;
Shah, D.
..
Value in Health. 23 (2020) - p. S455 , 2020
Link:
https://doi.org/10.1016/..
?
4
PCN42 Real-World Effectiveness in Previously Untreated, Adv..:
Trip, A.M.
;
May, J.
;
Malcolm, B.
...
Value in Health. 23 (2020) - p. S428 , 2020
Link:
https://doi.org/10.1016/..
?
5
Relationship Between Patient Characteristics and Outcomes I..:
Gonzalez-McQuire, S
;
Hensen, M
;
Spoorendonk, J
.
Value in Health. 18 (2015) 7 - p. A662 , 2015
Link:
https://doi.org/10.1016/..
?
6
Factors Influencing Dutch Drug Reimbursement Recommendation..:
Alleman, C.J.M.
;
Spoorendonk, J.A.
;
Charokopou, M.
..
Value in Health. 17 (2014) 7 - p. A441 , 2014
Link:
https://doi.org/10.1016/..
?
7
A Comparison of Factors Influencing Reimbursement and Cover..:
Charokopou, M.
;
Alleman, C.J.M.
;
Verleger, K.
...
Value in Health. 17 (2014) 7 - p. A430 , 2014
Link:
https://doi.org/10.1016/..
?
8
A cost-consequence model of using the 21-gene assay to iden..:
Simons, Martijn J. H. G.
;
Machielsen, Peter M.
;
Spoorendonk, Jelle A.
...
Journal of Medical Economics. 27 (2024) 1 - p. 445-454 , 2024
Link:
https://doi.org/10.1080/..
?
9
The feasibility of a 12-week progressive strength training ..:
Kierkegaard-Brøchner, S.
;
Kemp, J.
;
Lund, B.
...
Journal of Science and Medicine in Sport. 26 (2023) - p. S123-S124 , 2023
Link:
https://doi.org/10.1016/..
?
10
MSR97 Systematic Literature Review of the Efficacy and Safe..:
Spoorendonk, JA
;
Şahbaz Gülser, S
;
Arca`, E
...
Value in Health. 25 (2022) 12 - p. S368 , 2022
Link:
https://doi.org/10.1016/..
?
11
POSB97 Cost-Consequence Model of Using Gene Expression Test..:
de Jongh, FE
;
Efe, R
;
Herrmann, K
..
Value in Health. 25 (2022) 1 - p. S79-S80 , 2022
Link:
https://doi.org/10.1016/..
?
12
Cost and Clinical Benefits Associated with Oncotype DX® Tes..:
de Jongh, Felix E.
;
Efe, Reva
;
Herrmann, Kirsten H.
..
International Journal of Breast Cancer. 2022 (2022) - p. 1-12 , 2022
Link:
https://doi.org/10.1155/..
?
13
EE529 Modeling Studies of Human Papilloma Virus (HPV) Vacci..:
Wang, W
;
Jain, P
;
Santpurkar, N
...
Value in Health. 25 (2022) 12 - p. S160 , 2022
Link:
https://doi.org/10.1016/..
?
14
POSC64 Healthcare Costs and Resource Utilization in 1L Main..:
Heldt, D
;
Snedecor, SJ
;
Kalilani, L
...
Value in Health. 25 (2022) 1 - p. S98-S99 , 2022
Link:
https://doi.org/10.1016/..
?
15
CO49 Clinical Efficacy and Safety of Therapeutic Interventi..:
Jain, P
;
Badgujar, L
;
Spoorendonk, JA
.
Value in Health. 25 (2022) 7 - p. S312-S313 , 2022
Link:
https://doi.org/10.1016/..
1-15